Thrombosis (blood clots)
Disease Information
Research & Innovation
Children with thrombosis are treated through the Dana-Farber/Children's Hospital Cancer Center's Thrombosis Program and Anticoagulation Service. Alan Michelson, MD, our program’s director, is an expert in the field of platelets and platelet disorders. He is the editor of Platelets, the field’s premier academic text on these conditions. He also directs the Center for Platelet Research Studies, an internationally recognized, multi-disciplinary research center in thrombosis and anticoagulation.
The center’s researchers perform scientific and clinical research on platelets and related aspects of hemostasis and thrombosis. A particular focus is antiplatelet therapy, including the characterization of:
- how newly discovered molecules and mechanisms could help control platelets and clotting
- how antiplatelet drugs affect normal blood clotting (aka coagulation) and aspects of the immune system (e.g., inflammation)
- the relationship between the strength of antiplatelet treatments and the balance between thrombosis (uncontrolled clotting) and hemorrhage (uncontrolled bleeding)
- how tests of platelet function could help guide antiplatelet therapy in the clinic
Visit our research page for more information about current projects.
